Second Sight Medical Products
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Second Sight Medical Products generated cash of -$9,188,000, which is more than the previous year. Cash used in financing activities reached the amount of $75,616,000 last year. Net change in cash is therefore $66,416,000.
Cash Flow
| 2012 | -15.32M | -2.84M | 17.98M |
|---|---|---|---|
| 2013 | -17.42M | -4.54M | 21.97M |
| 2014 | -17.09M | -25.94M | 43.80M |
| 2015 | -20.54M | 17.51M | 2.75M |
| 2016 | -25.07M | 4.88M | 20.45M |
| 2017 | -23.94M | 2.84M | 21.16M |
| 2018 | -29.81M | -163K | 26.60M |
| 2019 | -27.62M | -493K | 34.98M |
| 2020 | -16.82M | 68K | 8.59M |
| 2021 | -9.18M | -14K | 75.61M |
EYES Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.17M | 11.32M | 4.47M | 7.83M | 539K | 239K | 619K | 62.56K | 144.75K | 372.74K |
Operating activities | ||||||||||
Net income | -8.92M | -14.88M | -33.59M | -35.09M | -28.51M | -33.17M | -20.01M | -35.20M | -22.96M | -16.27M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 70K | 164K | 397K | 435K | 457K | 432K | 335K | 279.17K | 315.77K | 324.71K |
Stock-based compensation expense | 75K | 421K | 2.92M | 3.58M | 3.78M | 3.36M | 2.68M | 1.47M | 769.89K | 907.86K |
| Deferred income tax benefit | 75K | 421K | 2.92M | 3.58M | 3.78M | 3.36M | 2.68M | 1.47M | 769.89K | 907.86K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 461K | 48K | 1.22M | -1.41M | 955K | -793K | -239.00K | -148.31K | 97.43K |
Inventories | 0 | 529K | -347K | -1.17M | 3.86M | 10K | -2.48M | -3.37M | -559.88K | -595.73K |
Accounts payable | 63K | -1.05M | -213K | 554K | -419K | 446K | 197K | 198.77K | -417.05K | 492.48K |
Cash generated by operating activities | -9.18M | -16.82M | -27.62M | -29.81M | -23.94M | -25.07M | -20.54M | -17.09M | -17.42M | -15.32M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25.38M | -4.30M | -2.65M |
Investments In Property Plant And Equipment | -14K | -330K | -493K | -163K | -265K | -490K | -762K | -560.35K | -246.00K | -196.08K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -14K | 68K | -493K | -163K | 2.84M | 4.88M | 17.51M | -25.94M | -4.54M | -2.84M |
Financing activities | ||||||||||
Common Stock Issued | 77.78M | 6.67M | 34.50M | 25.93M | 262K | 272K | 0 | 43.29M | 2.40M | 7.88M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -53.66K | 0 |
Cash used in financing activities | 75.61M | 8.59M | 34.98M | 26.60M | 21.16M | 20.45M | 2.75M | 43.80M | 21.97M | 17.98M |
Net Change In Cash | 66.41M | -8.15M | 6.85M | -3.36M | 65K | 300K | -380K | 556.84K | -82.18K | -227.99K |
Cash at end of period | 69.59M | 3.17M | 11.32M | 4.47M | 604K | 539K | 239K | 619.41K | 62.56K | 144.75K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |